How about getting things done by only thinking about it? Sounds good? But can’t fathom how that could work in the real world?

Neuralink has developed a brain chip which after implanting it in the human brain gives the person the ability to control a computer mouse by just thinking.

Trial patients will have a chip surgically placed in the part of the brain that controls the intention to move. The chip, which will be installed by a robot, will then record and send brain signals to an app, with the initial goal being “to grant people the ability to control a computer cursor or keyboard using their thoughts alone,” the company Neuralink wrote.

In late January 2024, the surgery took place, and Elon Musk stated,

“Progress is good, patient seems to have made a full recovery … and is able to control the mouse, move the mouse around the screen just by thinking.” 

  • 65% of respondents were aware of the first  Neuralink Brain Implant.
  • 58.65% of respondents are interested in using “Telepathy,” Neuralink’s first product
  • Experts raise health hazards while 71.07% agreed that mass production could violate a person’s privacy rights.

Initially, when Real Research asked respondents about the awareness of the first Neuralink brain implantation, 65% of respondents stated they were aware. 35% didn’t know about the Neuralink brain implant.

Neuralink-brain-computer
Fig.1: Around two-thirds of respondents were aware

In September 2023, the U.S. Food and Drug Administration (FDA) gave approval to the company to implant the chip on a human. When asked about the precision of the decision by the FDA, 65% of the respondents stated that it is right to approve the Neuralink Brain Implant by the FDA. However, 35% of respondents opposed the decision by the FDA.

Since Neuralink is still recruiting humans for its PRIME study on the safety of the implant and the robot, Real Research polled about the willingness of the respondents to participate in this campaign. 54.27% of respondents stated that they were willing to participate in the trial while 45.73% did not like participating Neuralink Brain Implant campaign.

Telepathy
Fig 2: Almost 60% were interested in using Telepathy

58.65% of respondents stated that they would be interested in using “Telepathy”, Neuralink’s first product that could enable the user to control a phone or computer by thinking. 41.35% of the respondents were not interested in using it.

70%-of-respondents-agree-with-the-experts-concerns
Fig 3: 70% of respondents agree with the experts’ concerns

Meanwhile, technical experts have raised concerns that Neuralink’s brain computer could cause devastating damage if there are technical issues. 70.75% of the respondents agreed with the expert’s concern while 29.25% were not concerned about this.

While experts raise concerns about health hazards, some other community members raised concerns about one’s privacy as governments and companies could easily monitor a person’s activities if the brain-computer is mass-produced in the future. 71.07% agreed that mass production could violate a person’s privacy rights while 28.93% did not.

66.33% of respondents agree with the social media users who speculated that the brain-computer would be used just like face and palm scanning devices while 33.67% disagreed with this statement.

Methodology

 
Survey TitleSurvey on Neuralink’s Brain-Computer Becoming a Reality
DurationFebruary 10 – February 17, 2024
Number of Participants6,000
DemographicsMales and females, aged 21 to 99
Participating Countries Afghanistan, Algeria, Angola, Argentina, Armenia, Australia, Azerbaijan, Bahrain, Bangladesh, Belarus, Benin, Bolivia, Brazil, Brunei, Bulgaria, Burkina Faso, Cambodia, Cameroon, Canada, Chile, China, China (Hong Kong) China (Macao), China (Taiwan), Colombia, Costa Rica, Croatia, Czech Republic, Ecuador, Egypt, El Salvador, Ethiopia, Finland, France, Gambia, Georgia, Germany, Ghana, Greece, Greanada, Guatemala, Honduras, Hungary, India, Indonesia, Iraq, Ireland, Israel, Italy, Ivory Coast, Japan, Jordan, Kenya, Kuwait, Kyrgyzstan, Latvia, Lebanon, Libya, Lithuania, Malaysia, Maldives, Maluritania, Mexico, Moldova, Mongolia, Morocco, Mozambique, Myanmar [Burma], Namibia, Nepal, Nicaragua, Nigeria, Oman, Pakistan, Palestine, Panama, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russia, Saudi Arabia, Serbia, Sierra Leone, Singapore, Slovakia, South Africa, South Korea, Spain, Sri Lanka, Tanzania, Thailand, Togo, Tunisia, Turkey, Turkmenistan, Uganda, Ukraine, United Arab Emirates, United Kingdom, United States, Uruguay, Uzbekistan, Venezuela, Vietnam, Yemen, Zimbabwe.